Ample epidemiological evidence indicates that individuals with obesity (particularly with morbid obesity), diabetes, metabolic syndrome, hypertension and coronary heart disease have decreased levels of adiponectin, with especially low HMW adiponectin [68][108–112]. The gene discussed is ADIPOQ; the disease is Obesity.